Lan‐Feng Dong

6.8k total citations
79 papers, 3.8k citations indexed

About

Lan‐Feng Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lan‐Feng Dong has authored 79 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 39 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Lan‐Feng Dong's work include Cancer, Hypoxia, and Metabolism (29 papers), Mitochondrial Function and Pathology (22 papers) and ATP Synthase and ATPases Research (19 papers). Lan‐Feng Dong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (29 papers), Mitochondrial Function and Pathology (22 papers) and ATP Synthase and ATPases Research (19 papers). Lan‐Feng Dong collaborates with scholars based in Australia, Czechia and Italy. Lan‐Feng Dong's co-authors include Jiřı́ Neužil, Stephen J. Ralph, Jakub Rohlena, Xiufang Wang, Renata Zobalová, Lubomír Procházka, Pauline Low, Marco Tomasetti, Marina Stantic and Jaroslav Truksa and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Lan‐Feng Dong

77 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan‐Feng Dong Australia 37 2.5k 1.2k 479 365 345 79 3.8k
Xiaozhuo Chen United States 27 2.1k 0.8× 932 0.8× 560 1.2× 237 0.6× 235 0.7× 73 3.6k
Bilal Bin Hafeez United States 36 1.9k 0.8× 699 0.6× 551 1.2× 230 0.6× 344 1.0× 82 3.7k
Geou‐Yarh Liou United States 19 2.1k 0.8× 809 0.7× 1.2k 2.5× 294 0.8× 167 0.5× 42 4.3k
Chiara Gorrini Canada 17 3.1k 1.2× 772 0.7× 773 1.6× 263 0.7× 118 0.3× 23 4.6k
Di Chen China 35 2.9k 1.2× 1.3k 1.1× 775 1.6× 378 1.0× 139 0.4× 96 4.4k
Huanjie Yang China 32 2.0k 0.8× 505 0.4× 721 1.5× 281 0.8× 140 0.4× 57 3.8k
Borhane Annabi Canada 41 2.2k 0.8× 1.2k 1.0× 1.1k 2.2× 216 0.6× 231 0.7× 151 4.8k
Srigiridhar Kotamraju India 37 2.4k 0.9× 524 0.4× 686 1.4× 686 1.9× 137 0.4× 82 5.3k
Julien Verrax Belgium 34 3.1k 1.2× 1.7k 1.5× 468 1.0× 369 1.0× 157 0.5× 53 5.0k

Countries citing papers authored by Lan‐Feng Dong

Since Specialization
Citations

This map shows the geographic impact of Lan‐Feng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan‐Feng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan‐Feng Dong more than expected).

Fields of papers citing papers by Lan‐Feng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan‐Feng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan‐Feng Dong. The network helps show where Lan‐Feng Dong may publish in the future.

Co-authorship network of co-authors of Lan‐Feng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Lan‐Feng Dong. A scholar is included among the top collaborators of Lan‐Feng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan‐Feng Dong. Lan‐Feng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Lan‐Feng, et al.. (2025). Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota. Journal of Nanobiotechnology. 23(1). 168–168. 5 indexed citations
3.
Dong, Lan‐Feng, et al.. (2025). Cationic Lipid‐Assisted PEG‐b‐PLA Nanoparticles Achieve Long‐Lasting Targeted Delivery of Natural Hydrophobic Antioxidants. Molecular Nutrition & Food Research. 69(6). e202400703–e202400703. 1 indexed citations
4.
Raninga, Prahlad V., Andy Lee, Debottam Sinha, et al.. (2020). Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition. Theranostics. 10(12). 5259–5275. 52 indexed citations
5.
Islam, Farhadul, et al.. (2018). Liposomal Delivery of miR-34b-5p Induced Cancer Cell Death in Thyroid Carcinoma. Cells. 7(12). 265–265. 37 indexed citations
6.
Boukalová, Štěpána, Jan Štursa, Lukáš Werner, et al.. (2016). Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer. Molecular Cancer Therapeutics. 15(12). 2875–2886. 62 indexed citations
7.
Murtaza, Mariyam, Nicholas Matigian, Michael Todorovic, et al.. (2016). Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson’s Disease. PLoS ONE. 11(4). e0154544–e0154544. 23 indexed citations
8.
Štícha, Martin, Jiří Černý, Tomáš Mráček, et al.. (2015). Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation. Cell Death and Disease. 6(5). e1749–e1749. 51 indexed citations
9.
Tomasetti, Marco, Linda Nocchi, Sara Staffolani, et al.. (2014). MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with the Mitochondrial Function. Antioxidants and Redox Signaling. 21(15). 2109–2125. 81 indexed citations
10.
Dong, Lan‐Feng & Jiřı́ Neužil. (2014). Mitochondria in Cancer. Progress in molecular biology and translational science. 127. 211–227. 31 indexed citations
11.
Kľučková, Katarína, et al.. (2012). Mitochondrial complex II, a novel target for anti-cancer agents. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1827(5). 552–564. 91 indexed citations
12.
Rodríguez‐Enríquez, Sara, Luz Hernández‐Esquivel, Álvaro Marín‐Hernández, et al.. (2012). Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1817(9). 1597–1607. 30 indexed citations
13.
Vališ, Karel, Lubomír Procházka, Evžen Bouřa, et al.. (2011). Hippo/Mst1 Stimulates Transcription of the Proapoptotic Mediator NOXA in a FoxO1-Dependent Manner. Cancer Research. 71(3). 946–954. 83 indexed citations
14.
Dong, Lan‐Feng, Gary Grant, Helen Maureen Massa, et al.. (2011). α‐Tocopheryloxyacetic acid is superior to α‐tocopheryl succinate in suppressing HER2‐high breast carcinomas due to its higher stability. International Journal of Cancer. 131(5). 1052–1058. 21 indexed citations
15.
Ito, Koichi, Samuel J. Cutler, Lan‐Feng Dong, et al.. (2011). Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis. 14(3). 293–307. 83 indexed citations
16.
Dong, Lan‐Feng, Emma Swettenham, Xiufang Wang, et al.. (2007). Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress. Cancer Research. 67(24). 11906–11913. 86 indexed citations
17.
Neužil, Jiřı́, Marco Tomasetti, Yan Zhao, et al.. (2007). Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The Importance of Being Redox-Silent. Molecular Pharmacology. 71(5). 1185–1199. 121 indexed citations
18.
Neužil, Jiřı́, Jeffrey C. Dyason, Ruth Freeman, et al.. (2007). Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. Journal of Bioenergetics and Biomembranes. 39(1). 65–72. 110 indexed citations
19.
Ralph, Stephen J., Pauline Low, Lan‐Feng Dong, Alfons Lawen, & Jiřı́ Neužil. (2006). Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents. Recent Patents on Anti-Cancer Drug Discovery. 1(3). 327–346. 85 indexed citations
20.
Dong, Lan‐Feng. (2003). Antineoplastic Effect of Monkshood Polysaccharide on Mice Transplanted with Tumor Lines of H22 and S180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaozhuo Chen Breakdown of academic impact, for papers by Bilal Bin Hafeez Breakdown of academic impact, for papers by Geou‐Yarh Liou Breakdown of academic impact, for papers by Chiara Gorrini Breakdown of academic impact, for papers by Di Chen Breakdown of academic impact, for papers by Huanjie Yang Breakdown of academic impact, for papers by Borhane Annabi Breakdown of academic impact, for papers by Srigiridhar Kotamraju Breakdown of academic impact, for papers by Julien Verrax
Rankless by CCL
2026